For research use only. Not for therapeutic Use.
Zerlasiran sodium is an apolipoprotein A (ApoA) synthesis reducer[1].
| Catalog Number | I040324 |
| Molecular Formula | C443H556F12N144Na38O277P40S10 |
| Purity | ≥95% |
| Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022. |
